ES0157261019
ES0157261019
LABORATORIOS FARMACEUTICOS ROVI
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 2.97B EUR | 2.96B EUR | 4.13B EUR | 3.25B EUR |
Enterprise Value | 2.96B EUR | 2.94B EUR | 4.15B EUR | 3.27B EUR |
Valuation Multiples | ||||
Trailing P/E | 16.04x | 15.98x | 31.33x | 26.55x |
Forward P/E | 17.29x | -- | -- | -- |
Price to Sales | 3.84x | 3.83x | 5.57x | 5.52x |
Price to Book | 4.24x | 4.22x | 6.13x | 4.89x |
EV/Revenue | 3.84x | 3.8x | 5.6x | 5.56x |
EV/EBITDA | 16.85x | 13.97x | 20.03x | 17.6x |
Price to FCF (P/FCF) | 17.72x | 16.82x | 36.24x | 29.88x |
EV/FCF | 17.7x | 16.71x | 36.39x | 30.1x |
FCF Yield | 5.64% | 5.95% | 2.76% | 3.35% |